Experienced in Nephrocalcinosis

Claudia A. Gagnon

Quebec, QC, CA 
Experienced in Nephrocalcinosis
Quebec, QC, CA 
OverviewLocationsClinical Research

Overview

Claudia Gagnon practices in Quebec, Canada. Ms. Gagnon is rated as an Experienced expert by MediFind in the treatment of Nephrocalcinosis. Her top areas of expertise are X-Linked Hypophosphatemia, Hypoparathyroidism, Hypophosphatemia, Gastric Bypass, and Gastrectomy.

Her clinical research consists of co-authoring 92 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Nephrocalcinosis.

Gender
Female

Locations

Quebec, QC, Canada
Other Locations
Canada
Montreal, QC, Canada
Laval, QC, Canada
Vandry, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]
Enrollment Status: Completed
Publish Date: June 09, 2023
Intervention Type: Biological
Study Drug: rhPTH(1-84)
Study Phase: Phase 4
Comparison of Ease of Use and Acceptability of Intranasal and Injectable Glucagon Among Providers Administering it to Children or Adolescents With Type 1 Diabetes
Comparison of Ease of Use and Acceptability of Intranasal and Injectable Glucagon Among Providers Administering it to Children or Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Determinants of Bone and Muscle Quality and Strength in Obesity With and Without Diabetes
Determinants of Bone and Muscle Quality and Strength in Obesity With and Without Diabetes
Enrollment Status: Completed
Publish Date: September 01, 2021
A Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients With Hypoparathyroidism
A Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients With Hypoparathyroidism
Enrollment Status: Terminated
Publish Date: June 11, 2021
Intervention Type: Drug
Study Phase: Phase 1
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
An Open-Label, Randomized, Crossover Study to Assess the Pharmacokinetic and Pharmacodynamic Profiles of Once Daily and Twice Daily Dose Regimens of Recombinant Human Parathyroid Hormone (rhPTH[1-84]) Administered Subcutaneously to Subjects With Hypoparathyroidism
Enrollment Status: Completed
Publish Date: May 25, 2021
Intervention Type: Drug
Study Phase: Phase 1
Role of Vitamin D in the Prevention and Treatment of Diseases Associated With Insulin Resistance
Role of Vitamin D in the Prevention and Treatment of Diseases Associated With Insulin Resistance
Enrollment Status: Completed
Publish Date: July 24, 2020
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
View 5 Less Clinical Trials

92 Total Publications

Hyperglycemia worsens gut bacterial infection through intestinal Wnt, but independent of endotoxemia or obesity.
Hyperglycemia worsens gut bacterial infection through intestinal Wnt, but independent of endotoxemia or obesity.
Journal: American journal of physiology. Endocrinology and metabolism
Published: August 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gagnon's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile